LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Medical/Disease Research/Clinical Labs MED
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. No bill numbers to date: BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act; Provisions regarding lab developed tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
| AMY MUHLBERG | N/A |
Medicare/Medicaid MMM
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate setting for certain diagnostics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY MUHLBERG | N/A |
Food Industry (safety, labeling, etc.) FOO
Draft regulation: Food Safety Modernization Act implementing regulations; Provisions regarding finished product testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY MUHLBERG | N/A |
Budget/Appropriations BUD
Omnibus Appropriation/CR/S. 1599, Sequestration/implementation of the Budget Control Act of 2011: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2013; Provisions regarding National Institutes of Health funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.